# Kent Pharmaceuticals (Kent Pharmaceuticals Limited) Private limited company registered in Ashford, classed under “Manufacture of basic pharmaceutical products”. - Company number: 03371228 - Status: Active - Type: Private limited company - Incorporated: 15 May 1997 - Registered office: 2nd Floor, Connect 38, 1 Dover Place, Ashford, Kent, TN23 1FB - Location: Ashford, Kent - Activity: Manufacture of basic pharmaceutical products ## Latest filed profit No profit figure in its latest filed accounts. Turnover, net assets, cash, staff, earlier years, ratios and owners are on the page for subscribers. ## Questions people ask ### What does Kent Pharmaceuticals do? Private limited company registered in Ashford, classed under “Manufacture of basic pharmaceutical products”. ### How much turnover does Kent Pharmaceuticals make? Answered on the page for FirmFacts Pro subscribers: https://firmfacts.co/company/kent-pharmaceuticals-03371228 ### Is Kent Pharmaceuticals profitable? Kent Pharmaceuticals's profit isn't public: small companies may file without a profit and loss account. ### Who runs and owns Kent Pharmaceuticals? Its directors are Kevin James, Gavin McGowan, Jack McGowan, Larry McGowan, Olivia Regan. Its owners are shown to subscribers. ### Where is Kent Pharmaceuticals based? Its registered office is 2nd Floor, Connect 38, 1 Dover Place, Ashford, Kent, TN23 1FB, in Ashford, Kent. ### When was Kent Pharmaceuticals founded? Kent Pharmaceuticals Limited was incorporated on 15 May 1997. ### Is Kent Pharmaceuticals still trading? The register lists Kent Pharmaceuticals Limited as active. ## Timeline Recent filings and changes at Companies House. - 2026-11-02: Audit exemption subsidiary accounts made up to 31 March 2026 - 2026-11-02: Notice of agreement to exemption from audit of accounts for period ending 31/03/26 - 2026-10-29: Appointment of Ms Olivia Regan as a director on 18 September 2026 - 2026-10-29: Appointment of Mr Larry Mcgowan as a director on 18 September 2026 - 2026-10-29: Appointment of Mr Jack Mcgowan as a director on 18 September 2026 - 2026-10-29: Appointment of Mr Gavin Mcgowan as a director on 18 September 2026 - 2026-10-29: Termination of appointment of David Wright as a director on 18 September 2026 - 2026-10-02: Consolidated accounts of parent company for subsidiary company period ending 31/03/26 - 2026-10-02: Audit exemption statement of guarantee by parent company for period ending 31/03/26 (and 4 more like it since 24 May 2023) - 2026-09-30: Satisfaction of charge 033712280004 in full - 2026-09-30: Satisfaction of charge 033712280003 in full - 2026-09-25: Registration of charge 033712280005, created on 18 September 2026 - 2026-01-26: Audit exemption subsidiary accounts made up to 31 March 2025 - 2026-01-26: Consolidated accounts of parent company for subsidiary company period ending 31/03/25 (and 1 more like it since 9 January 2026) - 2026-01-09: Notice of agreement to exemption from audit of accounts for period ending 31/03/25 - 2025-02-27: Audit exemption subsidiary accounts made up to 31 March 2024 - 2025-02-27: Consolidated accounts of parent company for subsidiary company period ending 31/03/24 - 2025-02-27: Notice of agreement to exemption from audit of accounts for period ending 31/03/24 - 2024-06-01: Director's details changed for Mr David Wright on 1 June 2024 - 2024-01-15: Audit exemption subsidiary accounts made up to 31 March 2023 - 2024-01-15: Consolidated accounts of parent company for subsidiary company period ending 31/03/23 - 2024-01-15: Notice of agreement to exemption from audit of accounts for period ending 31/03/23 - 2023-07-04: Audit exemption subsidiary accounts made up to 31 March 2022 - 2023-07-04: Notice of agreement to exemption from audit of accounts for period ending 31/03/22 - 2023-06-27: Change of details for Kent Pharma Holdings Limited as a person with significant control on 4 May 2022 --- Source: Companies House filings (Open Government Licence v3.0). Figures are as filed; nothing is estimated. Page: https://firmfacts.co/company/kent-pharmaceuticals-03371228